SAXENA PARAG 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 9:31 pm Purchase |
2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
SAXENA PARAG | 6,268,906 12.400% |
17,300 (+0.28%) |
Filing |
| 2024-08-23 4:07 pm Purchase |
2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
SAXENA PARAG | 6,251,606 16.900% |
6,251,606 (New Position) |
Filing |